Key Event Details
The Nomination and Remuneration Committee of the Board of Directors of Thyrocare Technologies Limited approved, via circular resolution passed on November 06, 2026, the allotment of 1,94,289 (One Lakh Ninety Four Thousand Two Hundred and Eighty Nine) Equity Shares of ₹10 each under the Thyrocare Employee Stock Option Scheme (ESOS).
Quantitative Details
The allotment includes 1,29,526 equity shares pursuant to bonus adjustment. The equity shares allotted will rank pari passu in all respects with the existing equity shares of the Company.
Capital Structure Impact
Consequent to the allotment, the issued, subscribed and paid-up equity share capital of the Company changed as follows:
| Particulars | No. of Shares | Amount (₹) |
| Before allotment | 15,91,65,315 | 1,59,16,53,150 |
| Equity shares allotted pursuant to ESOS | 1,94,289 | 19,42,890 |
| Post allotment | 15,93,59,604 | 1,59,35,96,040 |
Additional Procedures
The Company is applying for listing and trading approvals with National Stock Exchange of India Limited and BSE Limited for the allotted equity shares, in accordance with applicable requirements.
Disclosure Availability
The disclosure is available on the company website at https://investor.thyrocare.com/announcements/.